179 related articles for article (PubMed ID: 14679001)
41. Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3.
Holzapfel K; Müller SA; Seidl C; Grosu AL; Schwaiger M; Senekowitsch-Schmidtke R
Strahlenther Onkol; 2008 Jun; 184(6):319-24. PubMed ID: 18535808
[TBL] [Abstract][Full Text] [Related]
42. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
Cheung R; Tucker SL; Lee AK; de Crevoisier R; Dong L; Kamat A; Pisters L; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):993-1002. PubMed ID: 15752878
[TBL] [Abstract][Full Text] [Related]
43. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
Gavrilov V; Steiner M; Shany S
Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
45. The roles of epithelial-mesenchymal interactions and the innate immune response on the tumorigenicity of human prostate carcinoma cell lines grown in immuno-compromised mice.
Frost GI; Dudouet B; Lustgarten J; Borgström P
In Vivo; 2003; 17(5):377-88. PubMed ID: 14598599
[TBL] [Abstract][Full Text] [Related]
46. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
47. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W; Yacoub S; Shiverick KT; Namiki K; Sakai Y; Porvasnik S; Urbanek C; Rosser CJ
Prostate; 2008 Aug; 68(11):1223-31. PubMed ID: 18465755
[TBL] [Abstract][Full Text] [Related]
48. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
49. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
50. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
Huynh H; Nguyen TH; Panasci L; Do P
Cancer; 2004 Dec; 101(12):2881-91. PubMed ID: 15529313
[TBL] [Abstract][Full Text] [Related]
51. The role of heat shock protein 70 in the thermoresistance of prostate cancer cell line spheroids.
Khoei S; Goliaei B; Neshasteh-Riz A; Deizadji A
FEBS Lett; 2004 Mar; 561(1-3):144-8. PubMed ID: 15013766
[TBL] [Abstract][Full Text] [Related]
52. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
[TBL] [Abstract][Full Text] [Related]
53. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
54. Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).
Ballangrud AM; Yang WH; Charlton DE; McDevitt MR; Hamacher KA; Panageas KS; Ma D; Bander NH; Scheinberg DA; Sgouros G
Cancer Res; 2001 Mar; 61(5):2008-14. PubMed ID: 11280760
[TBL] [Abstract][Full Text] [Related]
55. Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model.
Kwok CS; Crivici A; MacGregor WD; Unger MW
Cancer Res; 1989 Jun; 49(12):3276-81. PubMed ID: 2720681
[TBL] [Abstract][Full Text] [Related]
56. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions.
Pollack A; Ashoori F; Sikes C; Joon DL; von Eschenbach AC; Zagars GK; Meistrich ML
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):153-8. PubMed ID: 10656387
[TBL] [Abstract][Full Text] [Related]
57. Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma.
Sminia P; Acker H; Eikesdal HP; Kaaijk P; Enger Pø; Slotman B; Bjerkvig R
Anticancer Res; 2003; 23(2B):1461-6. PubMed ID: 12820410
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models.
Chung YL; Troy H; Banerji U; Jackson LE; Walton MI; Stubbs M; Griffiths JR; Judson IR; Leach MO; Workman P; Ronen SM
J Natl Cancer Inst; 2003 Nov; 95(21):1624-33. PubMed ID: 14600095
[TBL] [Abstract][Full Text] [Related]
59. Cytotoxicity of hypoxic cell sensitizers in multicell spheroids.
Sutherland RM; Bareham BJ; Reich KA
Cancer Clin Trials; 1980; 3(1):73-83. PubMed ID: 7389039
[TBL] [Abstract][Full Text] [Related]
60. Quantitative distinction of cisplatin-sensitive and -resistant mouse fibrosarcoma cells grown in multicell tumor spheroids.
Frenzel KR; Saller RM; Kummermehr J; Schultz-Hector S
Cancer Res; 1995 Jan; 55(2):386-91. PubMed ID: 7812971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
